Alcon is the leading manufacturer of intraocular lenses. Of the 20 million cataract procedures conducted globally each year, only 4% of patients receive PC-IOLs. Now, with a lens that offers a visual ...

Basel, Switzerland, July 1, 2015 – Alcon, the global leader in eye care and a division of Novartis, has received European CE Mark for its AcrySof® IQ Aspheric IOL with the UltraSert™ Pre-loaded ...

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...

The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, has received European CE Mark for its AcrySof IQ PanOptix trifocal intraocular lens (IOL) for patients ...

TORONTO, Feb. 1, 2021 /CNW/ - Alcon, the global leader in eye care, is pleased to announce a nationwide launch of the Clareon ® intraocular lens (IOL) with the AutonoMe ® delivery system in Canada.

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...

Novartis’ Alcon earned a CE mark for its automated, disposable, preloaded intraocular lens delivery system. The company is introducing the device, dubbed AutonoMe, alongside its next-gen Clareon ...

Novartis' Alcon will introduce its recently CE-marked Clareon intraocular lens with an automated delivery system at the European Society of Cataract and Refractive Surgeons Congress next week. The ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available in select European ...

The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, has received European CE Mark for its AcrySof IQ Aspheric IOL with the UltraSertTM Pre-loaded Delivery System ...

Basel, October 5, 2015-Alcon, the global leader in eye care and a division of Novartis, has received US Food and Drug Administration (FDA) approval for its AcrySof ® IQ Aspheric IOL with the UltraSert ...